RecruitingNot ApplicableNCT06118346

A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings

A Female-Specific Cognitive Behavioral Therapy Group for Alcohol Use Disorder in VA Primary Care Settings


Sponsor

University of Massachusetts, Worcester

Enrollment

162 participants

Start Date

Feb 24, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria5

  • women aged 18 or older
  • Veteran of the U.S. Armed Forces
  • Enrolled in healthcare at VA NYHHS;
  • AUDIT-C ≥3 plus diagnosis of AUD and/or risky drinking (defined by the National Institute on Alcohol Abuse and Alcoholism as more than 3 drinks on any one day or more than 7 drinks per week) on more detailed screening
  • consumed alcohol within 90 days prior to our study's initial eligibility screen.

Exclusion Criteria3

  • participant is acutely suicidal
  • participant has acute psychotic or manic symptoms associated with severe mental illness
  • participant is pregnant at initial eligibility screen.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALFemale-Specific Cognitive Behavioral Therapy (FS-CBT)

FS-CBT is a unique 12-session weekly group CBT treatment designed for women Veterans with AUD and/or risky drinking, and provides (1) AUD interventions, (2) general female-specific content, (3) female-Veteran content, (4) wellness and self-care, and (5) a novel 24/7 social support for abstinence discussion mobile app.

BEHAVIORALUsual Care

Usual care means that participants will receive brief alcohol counseling and have access to available treatments for AUD at the VA.


Locations(1)

VA New York Harbor Healthcare System

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06118346


Related Trials